Entyvio® (Non-English)

Entyvio is a medicine used to treat adult patients with ulcerative colitis (a disease causing inflammation and ulcers in the lining of the bowel) or Crohn’s disease (a disease causing inflammation of the digestive tract). Entyvio is used to treat moderately to severely active disease when conventional therapy or medicines called TNF-alfa antagonists are ineffective, no longer effective, or cannot be tolerated by the patient.

Composition:

300 mg of vedolizumab

Side effects:

Although uncommon, it’s possible for Entyvio to cause eye-related side effects. Vision changes may be a sign of a serious condition called progressive multifocal leukoencephalopathy (PML). PML is a rare but serious infection in your brain that can cause blurry vision and loss of vision.

Package:

300mg x 1 Vial